Company
United StatesPublic company, NASDAQ: SINTSintx Technologies Inc (NASDAQ: SINT), Salt Lake City, UT – FDA Inspections
Inspection records and compliance data for Sintx Technologies Inc in Salt Lake City, Utah. 3 FDA inspections on record, 1 Form 483, last inspected March 10, 2017. Publicly traded as NASDAQ: SINT.
Company Profile
This profile covers Sintx Technologies Inc based in Salt Lake City, Utah, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 3
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
First inspected May 13, 2011. Last inspected March 10, 2017.
Most cited issue areas
- Lack of or inadequate procedures3 inspections
- Individual Report of Malfunction2 inspections
- Justification for not reporting2 inspections
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 10, 2017 | VAI | Medical Devices & Rad Health · Compliance: Devices | 1007302 |
| May 9, 2014 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 879329 |
| May 13, 2011 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 724895 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Sintx Technologies Inc
Stock ticker
SINT
Exchange
NASDAQ
Share price
$1.54
Market cap
$11.6M
Price as of
November 13, 2026
FEI Number
3005032068
Address
1885 W 2100 S, Salt Lake City, Utah 84119, United States
Country
United States
ID: 76601667-b9b4-48d1-8615-b2019b0693ac